USEFULNESS OF TISSUE POLYPEPTIDE ANTIGEN IN STAGING, MONITORING, AND PROGNOSIS OF LUNG-CANCER

被引：48

作者：

BUCCHERI, G ^{[1
]}

FERRIGNO, D ^{[1
]}

机构：

[1] A CARLE HOSP CHEST DIS,DEPT MED,CUNEO,ITALY

来源：

CHEST | 1988年 / 93卷 / 03期

关键词：

D O I：

10.1378/chest.93.3.565

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

收藏

页码：565 / 570

页数：6

相关论文

共 30 条

[21]

2-6

[22]

NEMOTO T, 1979, J NATL CANCER I, V63, P1247

[23]

PAU F, 1985, MIN PNEUM, V24, P27

[24] DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .2. ANALYSIS AND EXAMPLES [J].

PETO, R ;

PIKE, MC ;

ARMITAGE, P ;

BRESLOW, NE ;

COX, DR ;

HOWARD, SV ;

MANTEL, N ;

MCPHERSON, K ;

PETO, J ;

SMITH, PG .

BRITISH JOURNAL OF CANCER, 1977, 35 (01) :1-39

[25] TUMOR-MARKERS IN BRONCHOGENIC-CARCINOMA - AN EVALUATION OF CARCINOEMBRYONIC ANTIGEN, TISSUE POLYPEPTIDE ANTIGEN, PLACENTAL ALKALINE-PHOSPHATASE AND PSEUDOURIDINE [J].

RASMUSON, T ;

BJORK, GR ;

DAMBER, L ;

HOLM, SE ;

JACOBSSON, L ;

JEPPSSON, A ;

STIGBRAND, T ;

WESTMAN, G .

ACTA RADIOLOGICA ONCOLOGY, 1983, 22 (03) :209-214

[26]

Schultek T, 1985, Prax Klin Pneumol, V39, P962

[27]

SCHULTEK T, 1985, ARZTL LAB, V31, P273

[28]

SIEGEL S, 1956, NONPARAMETRIC STAT, P202

[29]

VOLPINO P, 1985, J NUCL MED ALLIED S, V29, P241

[30]

1978, TNM CLASSIFICATION M